These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10958258)

  • 1. The SSRI discontinuation syndrome.
    Haddad P
    J Psychopharmacol; 1998; 12(3):305-13. PubMed ID: 10958258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer antidepressants and the discontinuation syndrome.
    Haddad P
    J Clin Psychiatry; 1997; 58 Suppl 7():17-21; discussion 22. PubMed ID: 9219489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant discontinuation syndromes.
    Haddad PM
    Drug Saf; 2001; 24(3):183-97. PubMed ID: 11347722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
    Black K; Shea C; Dursun S; Kutcher S
    J Psychiatry Neurosci; 2000 May; 25(3):255-61. PubMed ID: 10863885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible explanation for dizziness following SSRI discontinuation.
    Smith PF; Darlington CL
    Acta Otolaryngol; 2010 Sep; 130(9):981-3. PubMed ID: 20144124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.
    Markowitz JS; DeVane CL; Liston HL; Montgomery SA
    Int Clin Psychopharmacol; 2000 Nov; 15(6):329-33. PubMed ID: 11110008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.
    Renoir T
    Front Pharmacol; 2013; 4():45. PubMed ID: 23596418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    Zajecka J; Tracy KA; Mitchell S
    J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    Price JS; Waller PC; Wood SM; MacKay AV
    Br J Clin Pharmacol; 1996 Dec; 42(6):757-63. PubMed ID: 8971432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant withdrawal - the tide is finally turning.
    Hengartner MP; Davies J; Read J
    Epidemiol Psychiatr Sci; 2019 Aug; 29():e52. PubMed ID: 31434594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SSRI discontinuation syndrome: incidence and differences on three groups of patients treated with paroxetine].
    Rusconi AC; Carlone C; Muscillo M; Coccanari de' Fornari MA; Podda L; Piccione M
    Riv Psichiatr; 2009; 44(3):169-75. PubMed ID: 20066803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
    Schatzberg AF; Haddad P; Kaplan EM; Lejoyeux M; Rosenbaum JF; Young AH; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():5-10. PubMed ID: 9219487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Abrupt Discontinuation of Antidepressants in Critically Ill Hospitalized Adults.
    Bainum TB; Fike DS; Mechelay D; Haase KK
    Pharmacotherapy; 2017 Oct; 37(10):1231-1240. PubMed ID: 28730691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
    Cosci F; Chouinard G; Chouinard VA; Fava GA
    Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series.
    Whittal ML; Otto MW; Hong JJ
    Behav Res Ther; 2001 Aug; 39(8):939-45. PubMed ID: 11480834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.
    van Geffen EC; Hugtenburg JG; Heerdink ER; van Hulten RP; Egberts AC
    Eur J Clin Pharmacol; 2005 Jun; 61(4):303-7. PubMed ID: 15906018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitor discontinuation syndrome: a review.
    Tamam L; Ozpoyraz N
    Adv Ther; 2002; 19(1):17-26. PubMed ID: 12008858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Bryois C; Rubin C; Zbinden JD; Baumann P
    Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delirium Associated With Fluoxetine Discontinuation: A Case Report.
    Fan KY; Liu HC
    Clin Neuropharmacol; 2017; 40(3):152-153. PubMed ID: 28452902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.